INmune Bio Stock Forecast

INMB's stock price has decreased by -82.03% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 analysts polled by S&P Global, INmune Bio stock has a consensus rating of "Strong Buy" and an average price target of $7.00. The average 1-year stock price forecast is 401.79% higher than the current stock price, while the lowest is $4.00 (+186.74%) and the highest is $9.00 (+545.16%).

Price Target: $7.00 (+401.79%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$7.00	$7.50	$9.00
Change	+186.74%	+401.79%	+437.63%	+545.16%

Analyst Ratings

The average analyst rating for INmune Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	3	3	3
Buy	1	1	1	1	1	1
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $8	Buy	Maintains	$8	+473.48%	May 9, 2026
James Molloy Alliance Global Partners	Alliance Global Partners	Buy Maintains $7	Buy	Maintains	$7	+401.79%	Apr 6, 2026
Elemer Piros Lucid Capital	Lucid Capital	Buy Upgrades $2 → $9	Buy	Upgrades	$2 → $9	+545.16%	Mar 11, 2026

Financial Forecast

Revenue This Year

n/a

from 50.00K

Revenue Next Year

1.99M

EPS This Year

-0.69

from -1.86

EPS Next Year

-1.11

from -0.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	181.00K	374.00K	155.00K	14.00K	50.00K	-	1.99M
Revenue Growth	1,545.46%	106.63%	-58.56%	-90.97%	257.14%	-	-
EPS	-1.88	-1.52	-1.67	-2.11	-1.86	-0.69	-1.11
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	4.1M
Avg	n/a	2.0M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.46	-1.14
Avg	-0.69	-1.11
Low	-1.03	-1.07

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.